相关实验视频

Updated: Aug 2, 2026

Technique of Subnormothermic Ex Vivo Liver Perfusion for the Storage, Assessment, and Repair of Marginal Liver Grafts

Technique of Subnormothermic Ex Vivo Liver Perfusion for the Storage, Assessment, and Repair of Marginal Liver Grafts

Published on: August 13, 2014

活体肺输液低温储存限制炎症和内皮功能障碍

Jean Selim¹, Julien De Wolf², Mathieu Soulie³

¹Department of Anesthesiology and Critical Care, Rouen, France; Univ Rouen Normandie, INSERM EnVI UMR 1096, Rouen, France.

Journal of cardiothoracic and vascular anesthesia

|July 30, 2025

概括

在ex vivo肺 perfusion (EVLP) 期间的温度变化会影响肺移植. 在EVLP后的低温储存可能会减少炎症和内皮功能障碍,但需要进一步的研究.

科学领域:

移植免疫学移植免疫学
器官的保存器官的保存
肺部医学肺部医学

背景情况:

活体肺输液 (ex vivo lung perfusion,简称EVLP) 涉及从静态冷储 (4°C) 到热再输液 (37°C) 的显著温度变化.
这些温度波动对肺移植质量的影响,特别是炎症和内皮功能,仍然未被探索.

研究的目的:

研究EVLP期间温度变化对捐赠肺移植中的炎症标志物和内皮功能障碍的影响.
评估特定生物标志物的变化与初级移植功能障碍的发展之间的关联.

主要方法:

在一个单一的大学医院进行了前性观察性研究.
使用EVLP评估了20个捐赠肺部.
在EVLP期间和之后的关键时间点测量了支持和抗炎细胞因子 (IL-1β,IL-8,IL-6,TNF-α,IL-10),葡萄糖生物标志物 (HS,SD1) 和内甲蛋白-1 (ET-1).

主要成果:

EVLP显著增加了IL-1β,IL-6,IL-8,IL-10,TNF-α和ET-1的水平.
在EVLP后的低温储存导致IL-10和TNF-α的增加,与第一个移植相比.
在低温储存期间IL-8,TNF-α和ET-1的变化与72小时的严重初级移植功能障碍有关.

结论:

在肺移植之前,EVLP后的低温储存可能会减轻炎症反应和内皮功能障碍.
一些观察到的差异的统计学意义有限,因此需要谨慎解释.
需要进一步的研究来验证这些发现及其临床影响.

关键词:

内皮质功能障碍在内皮质功能障碍活体肺外 perfusion 的情况.葡萄糖糖的性糖质 (glycocalyx) 是一种肺部移植肺部移植主要的移植功能障碍.系统性炎症系统性炎症

更多相关视频

Author Spotlight: Utilizing Next-Generation Polymerized Human Hemoglobin for Improved Donor Lung Evaluation and Preservation in Rats

Author Spotlight: Utilizing Next-Generation Polymerized Human Hemoglobin for Improved Donor Lung Evaluation and Preservation in Rats

Published on: June 14, 2024

Establishment of a Novel Ex Vivo Lung Perfusion System for Rat Lungs After Circulatory Death

Establishment of a Novel Ex Vivo Lung Perfusion System for Rat Lungs After Circulatory Death

Published on: October 18, 2024

相关概念视频

Decreased Body Temperature

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by sustained extreme cold exposure, and severe...

External and Internal Respiration

External and Internal Respiration

External respiration occurs in the lungs, and it is the first step in the journey of oxygen inside the body. When we inhale, oxygen enters our lungs and diffuses across the thin alveolar membrane. The alveoli are tiny, air-filled sacs that provide a vast surface area for gas exchange. Oxygen in the alveoli has a higher partial pressure (105 mmHg) than in the adjacent pulmonary capillaries (40 mmHg), establishing a pressure gradient. As a result, oxygen molecules move from the alveoli into the...

Acute Respiratory Failure-II

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

Acute Respiratory Failure-V

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...

Pneumothorax-I

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.

Atelectasis II: Pathophysiology

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...